Company: APM
Filing Date: 2025-12-05
Form Type: 424B5
Source: 0001213900-25-118752
Chunk: 359

Company: Aptorum Group Ltd
Filing Date: 2025-12-05
Form: 424B5
Chunk 359
---
 February 12 and August
12 in each year. ATL may pre-pay in whole or in part, the Principal Indebtedness of the Line of Credit, and all interest accrued at any
time prior to the Maturity Date, without penalty. Under the Agreements, in addition to certain standard covenants, we are also not permitted,
without the prior written consent of Aeneas Group and Jurchen to (i) liquidate, dissolve or wind-up our business and affairs; (ii) effect
any merger or consolidation transaction; (iii) sell, lease, transfer, license or otherwise dispose, in a single transaction or series
of related transactions, all or substantially all of our assets; or (iv) consent to any of the foregoing. The Agreements are subject to
standard events of default, which if not cured within the agreed upon cure period, permits Aeneas Group Limited or Jurchen, as applicable,
to declare the outstanding Principal Indebtedness immediately due and payable, to exercise any other remedy provided for in the Agreements
or any other right available to Aeneas Group Limited or Jurchen as provided at law or in equity. Jurchen and Aeanas Group Limited also
maintain the right to set-off during the term of the Agreements. As of the date hereof, the Company has not drawn down from the Line of
Credit.

On January 13, 2022, the Group
entered a line of credit facility with Libra to provide up to a total $1 million in line of credit debt financing for its daily operation
The line of credit is originally matured on January 12, 2023, and is extended for additional 3 years. The interest on the outstanding
principal indebtedness is at the rate of 10% per annum. As of the date hereof, $0.5 million is outstanding from Libra Sciences Limited.
For the six months ended June 30, 2025 and the year ended December 31, 2023 and December 31, 2024, the Group has assessed that
the amounts due from Libra Science Limited and its subsidiary are potentially unrecoverable, an allowance for credit loss amounting to
$nil, $0.5 million and $1,184 has been recognized for the six months ended June 30, 2025, the year ended December 31, 2023 and
December 31, 2024. Libra Science Limited